• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射组织型纤溶酶原激活剂用于功能性卒中模拟症

Intravenous tissue plasminogen activator in functional stroke mimics.

作者信息

Kowalska Magdalena M, Michałowska Małgorzata M, Leńska-Mieciek Marta M

机构信息

Department of Neurology and Epileptology, Centre of Postgraduate Medical Education, Orłowski Hospital, Warsaw, Poland.

出版信息

Postep Psychiatr Neurol. 2025 Mar;34(1):33-43. doi: 10.5114/ppn.2025.149942. Epub 2025 Apr 30.

DOI:10.5114/ppn.2025.149942
PMID:40376287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12076133/
Abstract

PURPOSE

Time pressure in the treatment of acute ischemic stroke patients generates difficult decisions for neurologists, sometimes resulting in stroke mimic patients receiving intravenous thrombolytic therapy. Proper diagnosis and appropriate treatment for these patients are crucial, yet incredibly challenging in cases of functional stroke mimics (FSM).

VIEWS

Functional neurological disorders, including FSM, are increasingly diagnosed. However, their pathophysiology and underlying mechanisms are poorly understood, even though the diagnostic criteria for diagnosing FSM exist, and various clinical indicators support them. Functional neurological symptoms often result in serious disability for patients but the effective treatment is unknown. Neurologists need to examine the symptoms and the key clinical findings to distinguish between FSM and stroke. The intravenous thrombolytic therapy appears safe for FSM, but the potential harm of thrombolysis should be a concern. FSMdiagnosed patients require long-term treatment, starting with open and clear communication about their condition and followed by psychoeducation and physiotherapy.

CONCLUSIONS

FSM should be diagnosed using the diagnostic criteria. Electronic health information exchange among healthcare providers is necessary to avoid unnecessary thrombolytic treatments in this group of patients.

摘要

目的

急性缺血性中风患者的治疗时间紧迫,这给神经科医生带来了艰难的决策,有时会导致疑似中风的患者接受静脉溶栓治疗。对这些患者进行正确诊断和适当治疗至关重要,但在功能性中风模拟(FSM)病例中极具挑战性。

观点

包括FSM在内的功能性神经障碍的诊断越来越多。然而,尽管存在诊断FSM的标准且有各种临床指标支持,但对其病理生理学和潜在机制的了解却很少。功能性神经症状常常导致患者严重残疾,但有效的治疗方法尚不清楚。神经科医生需要检查症状和关键临床发现,以区分FSM和中风。静脉溶栓治疗对FSM似乎是安全的,但溶栓的潜在危害应引起关注。被诊断为FSM的患者需要长期治疗,首先要就其病情进行开放和清晰的沟通,然后进行心理教育和物理治疗。

结论

应使用诊断标准来诊断FSM。医疗服务提供者之间进行电子健康信息交换对于避免对这组患者进行不必要的溶栓治疗是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fa/12076133/d436c0335417/PPN-34-56001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fa/12076133/f42f97e37a73/PPN-34-56001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fa/12076133/d436c0335417/PPN-34-56001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fa/12076133/f42f97e37a73/PPN-34-56001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44fa/12076133/d436c0335417/PPN-34-56001-g002.jpg

相似文献

1
Intravenous tissue plasminogen activator in functional stroke mimics.静脉注射组织型纤溶酶原激活剂用于功能性卒中模拟症
Postep Psychiatr Neurol. 2025 Mar;34(1):33-43. doi: 10.5114/ppn.2025.149942. Epub 2025 Apr 30.
2
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
3
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
4
Clinical and Epidemiological Characteristics of Patients with Functional Stroke Mimics: A Case-Control Study from Southern Portugal.疑似功能性卒中患者的临床和流行病学特征:来自葡萄牙南部的一项病例对照研究。
Brain Sci. 2025 Feb 7;15(2):163. doi: 10.3390/brainsci15020163.
5
Functional Stroke Mimics: Incidence and Characteristics at a Primary Stroke Center in the Middle East.功能性卒中模拟:中东一家初级卒中中心的发生率和特征。
Psychosom Med. 2018 Jun;80(5):416-421. doi: 10.1097/PSY.0000000000000563.
6
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.急性缺血性卒中的溶栓治疗(不同剂量、给药途径和药物)
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD000514. doi: 10.1002/14651858.CD000514.pub3.
7
Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.血管内溶栓治疗酷似卒中患者:来自 SITS 国际卒中溶栓登记研究的结果。
Eur J Neurol. 2019 Aug;26(8):1091-1097. doi: 10.1111/ene.13944. Epub 2019 Mar 25.
8
High mimic rate among recipients of intravenous thrombolysis for acute minor ischemic stroke presenting with disabling symptoms.有致残症状的急性轻度缺血性卒中静脉溶栓治疗患者中的高模仿率。
J Stroke Cerebrovasc Dis. 2025 Jun;34(6):108298. doi: 10.1016/j.jstrokecerebrovasdis.2025.108298. Epub 2025 Apr 4.
9
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2000(2):CD000213. doi: 10.1002/14651858.CD000213.
10
Intravenous Tissue Plasminogen Activator in Stroke Mimics.静脉注射组织型纤溶酶原激活剂治疗疑似中风患者
Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

本文引用的文献

1
Diagnosing Functional Neurological Disorder through History and Physical Examination: A Case Report.通过病史和体格检查诊断功能性神经障碍:一例报告
Brown J Hosp Med. 2023 Apr 1;2(2):72763. doi: 10.56305/001c.72763. eCollection 2023.
2
Circulating Blood-Brain Barrier Proteins for Differentiating Ischaemic Stroke Patients from Stroke Mimics.用于区分缺血性脑卒中患者和脑卒中模拟患者的循环血脑屏障蛋白。
Biomolecules. 2024 Oct 22;14(11):1344. doi: 10.3390/biom14111344.
3
Characteristics and predictors of stroke mimics in young patients in the norwegian tenecteplase stroke trial (NOR-TEST).
挪威替奈普酶溶栓治疗试验(NOR-TEST)中青年脑卒中患者中脑卒中模拟的特征及预测因素。
BMC Neurol. 2023 Nov 15;23(1):406. doi: 10.1186/s12883-023-03425-x.
4
Functional Neurological Disorder: Diagnostic Pitfalls and Differential Diagnostic Considerations.功能性神经障碍:诊断陷阱与鉴别诊断考量
Neurol Clin. 2023 Nov;41(4):665-679. doi: 10.1016/j.ncl.2023.04.001. Epub 2023 May 22.
5
Thrombolysis in Stroke Mimics: Comprehensive Stroke Centers vs Telestroke Sites.疑似卒中的溶栓治疗:综合卒中中心与远程卒中站点
Can J Neurol Sci. 2023 Nov;50(6):838-844. doi: 10.1017/cjn.2022.325. Epub 2022 Dec 1.
6
Clinical application of brain perfusion imaging in detecting stroke mimics: A review.脑灌注成像在检测类卒中中的临床应用:综述。
J Neuroimaging. 2023 Jan;33(1):44-57. doi: 10.1111/jon.13061. Epub 2022 Oct 7.
7
Tenecteplase in Ischemic Stroke: Challenge and Opportunity.替奈普酶治疗缺血性卒中:挑战与机遇
Neuropsychiatr Dis Treat. 2022 May 11;18:1013-1026. doi: 10.2147/NDT.S360967. eCollection 2022.
8
Functional neurological disorder: new subtypes and shared mechanisms.功能性神经障碍:新亚型和共同机制。
Lancet Neurol. 2022 Jun;21(6):537-550. doi: 10.1016/S1474-4422(21)00422-1. Epub 2022 Apr 14.
9
Ischemic stroke mimics: A comprehensive review.缺血性脑卒中模拟疾病:全面综述。
J Clin Neurosci. 2021 Nov;93:174-182. doi: 10.1016/j.jocn.2021.09.025. Epub 2021 Sep 20.
10
Incidence and prevalence of psychogenic nonepileptic seizures in a Norwegian county: A 10-year population-based study.挪威某郡心因性非癫痫性发作的发病率和患病率:一项基于人群的10年研究。
Epilepsia. 2021 Jul;62(7):1528-1535. doi: 10.1111/epi.16949. Epub 2021 Jun 2.